Method for manufacturing high purified factor ó¨

A blood coagulation factor and factor technology, which is applied in the field of preparation of human coagulation factor IX, can solve problems such as inability to use, filter clogging, and inability to rule out side effects

Active Publication Date: 2008-10-22
THE GREEN CROSS CORP
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

And, there is also a more effective nanofiltration method that utilizes nanofiltration (nanofilter, 20nm), but when utilizing this nanofiltration, it is necessary to carry out a high-purity concentration process to the blood coagulation factor in advance, so as to prevent it from occurring in the use of non-high-purity When the prepared coagulation factor is subjected to nanofiltration, the filter is clogged and cannot be used
Although fa

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for manufacturing high purified factor ó¨
  • Method for manufacturing high purified factor ó¨
  • Method for manufacturing high purified factor ó¨

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Specific activityaaaaaaaaaa
Login to view more

Abstract

The present invention discloses a preparation method of a highly purified human blood coagulation factor IX. The human blood coagulation factor IX is prepared by performing anion exchange chromatography, cation exchange chromatography, heparin affinity chromatography to the material containing human blood coagulation factor IX (taken from human blood serum or recombined cell culture medium), which includes the period of passivating virus through S/D treatment (Solvent/Detergent treatment) or removing virus through nanofiltration. The highly purified safe coagulation factor IX preparation having a specific activity of above 150 IU/mg, with substantially undoped proteins can be prepared by the preparation method of the invention.

Description

A kind of preparation method of high-purity human coagulation factor IX technical field The present invention relates to a preparation method of high-purity human coagulation factor IX, in particular to a method by performing ion-exchange chromatography and affinity layer on a substance containing coagulation factor IX (taken from human plasma or recombined cell culture medium). In the stage of virus inactivation or virus removal by analysis, the safe high-purity coagulation factor IX with almost no adulterant protein and specific activity (specific activity) above 150IU / mg can be produced. Background technique Human coagulation factor IX is an indispensable glycoprotein in the blood coagulation process. If there is no coagulation factor IX or insufficient coagulation factor IX in the blood due to genetic factors or pathological factors, the coagulation process in the blood will be incomplete. , causing hemophilia B. Hemophilia B mainly occurs through heredity. One in 30...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K1/14
CPCC12Y304/21022C12N9/644C07K1/14
Inventor 姜镛崔龙云孙基桓李成来成学模金基镕许在旭
Owner THE GREEN CROSS CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap